Sunday, 31 August 2008

Mp3 music: Downer






Downer
   

Artist: Downer: mp3 download


   Genre(s): 

Other

   







Downer's discography:


Downer
   

 Downer

   Year: 2001   

Tracks: 11






Releasing hardy creations elysian by the furious simon Marks of the hardcore manner, Downer gives away groundbreaking ceremony themes supported within the domains of alternative alloy. Downer started forming in the thickset of the '90s in the Orange County surface area; however, the band's rootage goes gage to the mid-'80s, when guitar participant Aaron Silberman and vocalizer J. Scott low met. After haphazardly playing with diverse bands and working within the music industry's burden, they finally settled on aggregation their possess bunch. Following the accession of bassist Jed Hathaway and drummer John Dahlgren, Downer eventually collected, speedily initiating the initiation of their own wakeless. In 1995, the squad offered their kickoff base phonograph recording, the EP Pinman, delivered through and through Ammunition Records. Two years after, the full-length Wrestling With Jesus assured the topper extension for the band's audacious sound whole kit. It was too by that prison term that Downer entered their low major tour, alongside crews such as Ignite and Earth Crisis. The subsequent months were passed playing on the wish microscope stage as Korn, the Deftones, or Sublime. It was then that the group finally settled on sign language their number one major deal with Roadrunner, at the same sentence preparing to record what off out to be their instant record album. Securing the production duties of Bob Marlette, whose premature experiences included the works with bands like Saliva or Strife, the Californians issued their second major record, the self-titled Downer, that hit the phonograph recording stores in 2001.





Download Trial Of The Bow mp3

Friday, 22 August 2008

Lights are on, but nobody's home

Toronto space has so far to attract Hollywood major




TORONTO -- Filmport, Toronto's mega-studio and a possible white knight for its isolated film-production sector, opened its doors Wednesday with just one problem -- no studio tenant.

Phase 1 of the $60 million studio complex, which comprises seven-spot stages covering 260,000 square feet of blank, is so far without a Hollywood major on board as the studio-SAG contract dialogue in Los Angeles drag on.

Filmport Studios president Ken Ferguson predicts the complex will fill up one time the major league reach a new consider with the actors guild.

"In these challenging times for the Toronto film manufacture, we required a boost. We hope Filmport fanny play a role in putting Toronto where it belongs, back on top," he aforementioned at a ribbon-cutting ceremony attended by Mayor David Miller and Canadian theater director David Cronenberg.

Filmport, which includes a pillar-free 46,500-square-foot stage for effects-heavy studio pictures, already has chartered out power space to George A. Romero's "Diary of the Dead 2," which is shooting on location in Toronto.

Additionally, Universal is eyeing Filmport for its "Scott Pilgrim vs. the World" externalize, which is based on a amusing by local writer Bryan Lee O'Malley and congeal in Toronto. But with the Canadian dollar at near-parity with the American greenback, and New York offering a 35% tax credit, Universal producers besides are considering the Big Apple as a stand in for Toronto.

Paul Bronfman, chairman of Comweb, which has a near-half stake in Filmport, said that the mega-studio and Toronto will have to work operose to secure big-budget studio apartment shoots after a SAG deal is inked.

"It will be tough. But we'll find a way," Bronfman said.


More info

Tuesday, 12 August 2008

Brachytherapy Vs. Cryoablation In The Treatment Of Prostate Cancer

�UroToday.com - Both cryoablation and brachytherapy are well studied alternatives to radical prostatectomy. The techniques ar similar in the coating of the needles to deliver the treatment, planning software and algorithms to achieve the best coverage, are delivered as outpatient treatment, and efficacy. The techniques disagree in that cryoablation throne be utilised for irradiation failures and can be repeated.


There is a significant body of literature on brachytherapy and the controversies ar centered around the isotope used and the dosimetry. While in that respect may be some theoretic advantages to Pd103 in high risk tumors, there is no significant clinical data exhibit an advantage over I125. Generally Pd103 is victimised in combination with external beam and I125 in monotherapy. Treatment planning bathroom be performed prior to implant (Preplan) or during the imbed (intraoperative planning). The advantage of the preplan is that the number of seeds ordered is exact, but it requires a separate visit for the planimetry and is less flexible if changes need to be made during the implant. Intraoperative planning may resultant role in order more seeds than mandatory, but results show a significant betterment in both D90 and V100 compared to preplanning.


Cryoablation has had a controversial history which has improved with the third base generation bringing devices. The needles are smaller and are able to deliver a more than precise ice ball than the prior technologies. The addition of thermocouples for monitoring temperature and the urethral cooling system device have dramatically reduced some of the worst complications antecedently reported with cryoablation including incontinence, tissue paper sloughing, and fistulae. The outcome database for cryoablation is comparatively small compared to brachytherapy, but appears equal in terms of cancer restraint at 5 years in some studies and inferior in others.1-3 Complications such as loss of sexual function and dissoluteness appear to be higher in patients undergoing cryoablation though the new course towards focal therapy may reduce these complications.4-7


There ar few studies directly comparing the 2 technologies, only QOL analysis by Hubosky et al showed that QOL next either therapy showed eq scores on both bowel and bladder function initially, but favourite cryoablation at 18 months.3 Sexual dysfunction was significantly more common with cryoablation both immediately after treatment and in thirster term watch up.

References:
1. Cohen JK, Miller RJ, Ahmed S, Lotz MJ, Baust J Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 71:515-8, 2008

2. Long JP, Bahn D, Lee F, et al. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. Mar 2001;57(3):518-23

3. Hubosky LB, Fabrizio MD, Schelhammer PF, Barone BB, Tepera CM, Given RW, Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life J Endourology 21:1521-1531, 2007.

4. Robinson JW, Donnelly BJ, Saliken JC, et al. Quality of life and sexuality of men with prostate genus Cancer 3 geezerhood after cryosurgery. Urology. Aug 2002;60(2 Suppl 1):12-8.

5. Cohen JK, Miller RJ, Rooker GM, Shuman BA. Cryosurgical ablation of the prostate: biennial prostate-specific antigen and biopsy results. Urology. Mar 1996;47(3):395-401

Ghafar MA, Johnson CW, De La Taille A, et al. Salvage cryotherapy using an argon based system for locally repeated prostate crab after radiation therapy: the Columbia receive. J Urol. Oct 2001;166(4):1333-7; word 1337-8.

6. Chin JL, Pautler SE, Mouraviev V, et al. Results of salvage cryoablation of the prostate gland after radiation: identifying predictors of treatment failure and complications. J Urol. Jun 2001;one hundred sixty-five(6 Pt 1):1937-41; discussion 1941-2

7. Pisters LL, von Eschenbach AC, Scott SM, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. Mar 1997;157


Presented by: Sam D. Graham, Jr., MD, at the Masters in Urology Meeting - July 31, 2008 - August 2, 2008, Elbow Beach Resort, Bermuda

UroToday - the only if urology internet site with original content written by orbicular urology samara opinion leadership actively engaged in clinical practice.


To memory access the latest urology news releases from UroToday, go to:
www.urotoday.com


Copyright � 2008 - UroToday



More information

Wednesday, 6 August 2008

Quark Pharmaceuticals Announces First Patient Dosing By Pfizer In Phase II Trial Of RNAi Therapy In Diabetic Macular Edema

�Quark Pharmaceuticals, Inc., a
development-stage pharmaceutical company discovering and developing novel
RNA interference (RNAi)-based therapeutics, today announced that its
partner, Pfizer Inc, initiated patient dosing in a Phase II